CNTX Stock Analysis: Buy, Sell, or Hold?
CNTX - Context Therapeutics Inc. Common Stock
$2.61
0.14 (5.67%)
▲
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Mar 19, 2026
Get Alerted When CNTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called CNTX this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: CNTX is 28.6% above fair value ($2.03). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: CNTX is 28.6% above fair value ($2.03). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: CNTX is currently trading at $2.61, which is considered extended relative to its 30-day fair value range of $1.24 to $2.03.
Technical Outlook: Technically, CNTX is in a uptrend. Immediate support is located at $1.39, while resistance sits at $2.85. The stock is showing strong short-term momentum, up 5.7% recently.
Market Sentiment: CNTX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.57 (+113.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CNTX is in a uptrend. Immediate support is located at $1.39, while resistance sits at $2.85. The stock is showing strong short-term momentum, up 5.7% recently.
Market Sentiment: CNTX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.57 (+113.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$1.24 -
$2.03
Company Quality Score
53/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
52.6%
Protect Your Profits
CNTX is technically overbought (RSI 86). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+28.6% above fair value)
- BULLISH: Strong technical setup (60/100)
- BULLISH: Strong upward momentum (+5.7%)
- BULLISH: Trading 113.5% below Wall St target ($5.57)
- WARNING: Recommendation downgraded due to 28.6% overvaluation
Fair Price Analysis
30-Day Fair Range
$1.24 -
$2.03
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$1.39
Resistance Level
$2.85
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-6.31
Wall Street Target
$5.57
(+113.5%)
Last updated: February 01, 2026 8:06 AM ET
Data refreshes hourly during market hours. Next update: 9:06 AM
Data refreshes hourly during market hours. Next update: 9:06 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CNTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 54 HOLD |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$486 | 45 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$500 | 62 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$91 | 64 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$830 | 52 HOLD |
Advanced CNTX Option Strategies
Professional options setups generated by AI based on today's CNTX price and gamma walls.
